Nepedia
Back to Discover
Advanced Reader
🧬

Atopic dermatitis

life science Maturity 7-9 Next article →

Atopic dermatitis, often called atopic eczema, is a chronic condition involving long-term skin inflammation. It affects approximately 20% of the population at some point in their lives. While the term "eczema" is a broad category for many skin irritations, atopic dermatitis is a specific type. It is characterized by intense itching, redness, and swelling.

Child with Eczema (34034003933)
Child with Eczema (34034003933)

In some cases, the skin may crack or ooze a clear fluid. Over time, constant irritation can cause the skin to thicken, a process known as lichenification. This condition is not contagious, meaning you cannot catch it from someone else.

The biological mechanism of atopic dermatitis involves a complex interaction between the skin barrier and the immune system. A healthy skin barrier acts as a protective shield. In people with this condition, the epidermal barrier is often disrupted. This disruption allows allergens to penetrate deeper into the skin layers. Once inside, these allergens activate inflammatory dendritic cells and innate lymphoid cells. These cells then attract Th2 CD4+ helper T cells to the area. This specific immune response triggers the release of inflammatory cytokines, such as IL-4, IL-13, and IL-31. These chemicals activate the Janus kinase (Jak) pathways, which lead to further inflammation and the release of IgE antibodies.

Pattern of atopic eczema varies with age
Pattern of atopic eczema varies with age

The physical presentation of the condition changes significantly as a person ages. In infants under one year old, the face and limbs are often the primary sites of irritation. As children grow, the pattern typically shifts to the flexural areas. These are the folds of the skin, such as the insides of the elbows and the backs of the knees.

Pattern of atopic eczema varies with age
Pattern of atopic eczema varies with age

In adults, the hands and feet are the most common locations for symptoms. Some people may also develop Dennie-Morgan infraorbital folds, which are prominent creases under the eyelids caused by swelling. Other visible signs include scaling, skin fissures, or postinflammatory pigmentation, which are marks that are lighter or darker than normal skin.

Researchers are investigating several factors that contribute to why this condition develops. Genetics play a major role, particularly regarding the filaggrin (FLG) gene. About 30% of people with atopic dermatitis have mutations in this gene. Filaggrin is a protein produced by keratinocytes that helps the skin release moisturizing factors and maintain a strong lipid matrix. Without enough filaggrin, the skin barrier becomes weak. Additionally, many patients have a history of atopy, which is a tendency to produce high levels of IgE antibodies. This often leads to coexisting conditions like asthma or allergic rhinitis.

Environmental exposures and lifestyle factors also appear to influence the prevalence of the condition. Since 1970, rates of atopic dermatitis in the US and UK have increased three- to sixfold. This rise is linked to industrial exposures, such as chemicals like xylene and diisocyanates. These substances can prevent skin bacteria from producing essential lipids and can directly activate itch receptors like TRPA1. Other environmental triggers include low humidity, low temperatures, and exposure to dust mites. Some scientists also study the hygiene hypothesis, which suggests that limited early-life exposure to certain microorganisms might affect immune system development. For example, growing up with dogs has been associated with a lower risk.

Managing atopic dermatitis involves several different medical approaches to reduce inflammation and protect the skin. Moisturizing creams are frequently used to enhance the skin barrier and prevent dryness. To control active flare-ups, doctors may prescribe anti-inflammatory corticosteroid creams. If these are not effective, calcineurin inhibitors like tacrolimus or pimecrolimus may be used. For very severe cases, systemic medicines such as cyclosporin, methotrexate, dupilumab, or baricitinib might be necessary. Some patients also find relief through phototherapy, which uses light to treat the skin. While antibiotics are generally not used, they may be prescribed if a secondary bacterial infection occurs.

Understanding atopic dermatitis helps connect dermatology to broader concepts of immunology and environmental science. The condition demonstrates how the body's internal defenses react to external triggers. It also shows the relationship between genetic health and environmental changes. While the condition can be difficult to manage, many people eventually outgrow it. By addressing both the skin barrier and the underlying immune response, medical science continues to find better ways to support those living with this chronic inflammation.

699 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

🖼️ Images & Media (2)
File:Child with Eczema (34034003933).jpg
Child with Eczema (34034003933).jpg
File:Pattern of atopic eczema varies with age.png
Pattern of atopic eczema varies with age.png
More to explore

🔬 Go deeper

More advanced topics to explore

🪜 Step back

Simpler topics to build understanding

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.